RxSight (RXST) Return on Capital Employed (2021 - 2026)

RxSight's Return on Capital Employed history runs 6 years deep, the most recent figure standing at 19.72% for Q1 2026.

• Quarterly Return on Capital Employed fell 714.0% year-over-year to 19.72% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 19.72% (down 714.0% YoY) and the FY2025 annual result came in at 16.68%, down 26.0% from the prior year.
• Return on Capital Employed was 19.72% for Q1 2026 at RxSight, down from 16.97% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 73.28% in Q3 2022 and bottomed at 60.1% in Q1 2024.
• A 5-year average of 4.72% and a median of 12.77% in 2024 frame the typical range for Return on Capital Employed.
• Annual changes were most pronounced in 2024 — Return on Capital Employed sank 7862 bps — and 2025, when it jumped 4752 bps.
• RxSight's Return on Capital Employed stood at 0.17% in 2022, then plunged by 27338 bps to 46.57% in 2023, then jumped by 73 bps to 12.77% in 2024, then sank by 33 bps to 16.97% in 2025, then fell by 16 bps to 19.72% in 2026.
• Business Quant data shows RXST's Return on Capital Employed at 19.72% in Q1 2026, 16.97% in Q4 2025, and 15.9% in Q3 2025.